Digoxin
Back to searchMolecule Structure
Scientific Name
Digoxin
Description of the Drug
Digoxin is a cardiac glycoside used in the treatment of mild to moderate heart failure and for ventricular response rate control in chronic atrial fibrillation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00390
http://www.drugbank.ca/drugs/DB00390
Brand Name(s)
Digamex, Digoxin, Digoxin pediatric, Lanoxicaps, Lanoxin, Lanoxin-125, Lanoxin pediatric, Lanoxin-pg, Vanoxin
Company Owner(s)
Vistapharm Inc, Mylan Pharmaceuticals Inc, Covis Pharma Gmbh, Wyeth Ayerst Laboratories, Hikma Pharmaceuticals International Ltd, Impax Laboratories Inc, Abraxis Pharmaceutical Products, Sandoz Inc, Sun Pharmaceutical Industries Inc, West-Ward Pharmaceuticals International Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium/potassium-transporting ATPase | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095186 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL20506 | ||||
| Human Metabolome Database | HMDB0001917 | ||||
| DrugBank | DB00390 | ||||
| PubChem: Thomson Pharma | 14840467 | 16531631 | |||
| PubChem | 2724385 | ||||
| Mcule | MCULE-8165628529 | ||||
| LINCS | LSM-2511 | ||||
| Nikkaji | J4.082G | ||||
| PDBe | DGX | ||||
| BindingDB | 46355 | ||||
| EPA CompTox Dashboard | DTXSID5022934 | ||||
| LipidMaps | LMST01120023 | ||||
| DrugCentral | 882 | ||||
| Metabolights | MTBLC4551 | ||||
| Brenda | 9930 | 229384 | 61332 | 229385 | 5369 |
| Guide to Pharmacology | 4725 | 4726 | |||
| GSRS | 45095b8b-e37d-43fb-b4a1-59deac2175d0 | ||||
| rxnorm | LANOXIN | DIGOXIN | |||
| PubChem: Drugs of the Future | 125299298 | ||||
| KEGG Ligand | C06956 | ||||
| ChEBI | 4551 | ||||
| ZINC | ZINC000242548690 |
